CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Herantis Pharma Oyj Company Snapshot
Herantis Pharma Oyj operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Herantis Pharma Oyj with three other miscellaneous service companies in Europe: Reneuron Group PLC of the United Kingdom (2016 sales of £29,000.00 [US$37,613.58 ] of which 100% was Cell-Based Therapies), Northern Bitcoin AG of Germany (27,565.62 Euro [US$30,799.62 ] ), and Nordic Nanovector Asa which is based in Norway (314,000.00 Norwegian Kroner [US$34,279.38 ] ).

Sales Analysis.
   
   
 
  Stock Performance Chart for Herantis Pharma Oyj
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 7.10
(Figures in Euro)
1 Week 0.7%   13 Weeks 0.0%  
4 Weeks 20.3%   52 Weeks 19.3%  
 
Herantis Pharma Oyj Key Data:
  Ticker: HRTIS Country: Finland
  Exchanges: HEL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 25,292
(Year Ending Jan 2017).
Employees: N/A
  Currency: Euro Market Cap: 43,042,238
  Fiscal Yr Ends: December Shares Outstanding: 6,062,287
  Share Type: Ordinary Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.